Efficacy Results Using a Novel Hidradenitis Suppurativa Endpoint, Hiscr (Hidradenitis Suppurativa Clinical Response), From The Placebo-Controlled Phase of a Phase 2 Adalimumab Study

✍ Scribed by Scheinfeld, N.S.; Sobell, J.M.; Gu, Y.; Sood, S.

• Book ID: 121947338
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 52 KB
• Volume: 62
• Category: Article
• ISSN: 1097-6760
• DOI: 10.1016/j.annemergmed.2013.07.244